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ABSTRACT
Over the past few years, there has been growing interest in neuro-responsive intracerebral local
treatments of seizures, such as focal drug delivery, focal cooling, or electrical stimulation. This
mode of treatment requires an effective intracerebral electroencephalographic acquisition system,
seizure detector, brain stimulator, and wireless system that consume ultra-low power. This review
focuses on alternative brain stimulation treatments for medically intractable epilepsy patients. We
mainly discuss clinical studies of long-term responsive stimulation and suggest safer optimized
therapeutic options for epilepsy. Finally, we conclude our study with the proposed low-power,
implantable fully integrated device that automatically detects low-voltage fast activity ictal onsets
and triggers focal treatment to disrupt seizure progression. The detection performance was
verified using intracerebral electroencephalographic recordings from two patients with epilepsy.
Further experimental validation of this prototype is underway.
Keywords: Electroencephalographic (EEG), seizure detector, focal drug delivery, focal cooling,
electrical stimulation and implantable device
1. INTRODUCTION
Approximately 4 million people in North America and at least 50 million people in the
world have epilepsy. Epilepsy is a common chronic neurological disorder characterized
by a predisposition to unprovoked recurrent seizures. A seizure is the manifestation of
an abnormal, hypersynchronous discharge of a population of cortical neurons [1].
Several causes may disturb the normal pattern of brain activity and trigger an epileptic
seizure, such as head injury, brain infection, developmental malformations, brain tumors,
cerebrovascular disease, vascular malformations, genetic disorders, and hippocampal
sclerosis.
Epileptic seizures may loosely be classified into two categories: focal (partial) and
generalized seizures. Focal indicates that the seizures originate primarily within
networks limited to one cerebral hemisphere, discretely localized (arrows in Fig. 1a) or
more widely distributed. Focal seizures may secondarily generalize as the epileptic
discharge spreads contralaterally.
Primary generalized epileptic seizures originate within, and rapidly engage,
bilaterally distributed networks (arrows in Fig. 1b). Figure 1 shows the invasive EEG
acquisition, which helps to find seizure type and epileptogenic zones. In this figure, the
partial seizure shows the sudden appearance of this typical low-voltage fast activity
recorded from the intracerebral contacts positioned over the epileptogenic zone (arrows
in Fig. 1a) and the generalized seizure shows the rhythmic pattern activity recorded
from many intracerebral contacts over a large area of brain (arrows in Fig. 1b).
However, electrographically, many seizure patterns are seen at seizure onset and there
is variability in the seizure pattern depending on the localization and etiology of the
seizure. The most common seizure onset patterns are low-voltage fast activity, high-
voltage fast activity, and the rhythmic spiking [1]. Clinically, these ictal discharges
usually lead to behavioral manifestations but may also be clinically silent (i.e., electrical
seizures), especially if the ictal discharges remain very focal (without spread), are brief
(a few seconds) and occur in non-eloquent cortex.
Antiepileptic drugs are the mainstay of treatment, but many patients have systemic
and central nervous system side effects and a third of them are refractory. Because most
drug-resistant epileptics suffer from focal epilepsy, these patients may benefit from
epilepsy surgery. Several studies have shown that resection of the epileptogenic zone
may lead to seizure freedom [2]. Success is dependent on the accurate localization and
complete resection of the epileptogenic zone. Unfortunately, not all refractory patients
with focal epilepsy benefit from resective surgery; some have an epileptogenic zone
overlying eloquent areas (language, primary motor or visual areas) that cannot be
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Figure 1. Typical epileptic seizure (a) partial and (b) generalized seizures.
resected without permanent sequelae, while others have multifocal epilepsy. Therefore,
the poor neurological outcome of these cases combined with the lack of efficacy and
adverse effects of antiepileptic drugs provide sufficient justification to have an
alternative treatment to supplement conventional treatments. Given the therapeutic
needs, neurostimulation has been proposed as an alternative treatment.
Over the last quarter of the century, the vast progression in neuro-technology has
allowed the development of FDA-approved stimulators for the treatment of neurological
disorders, such as multi-channel cochlear implant for hearing loss, deep brain
simulation for Parkinson’s disease, and vagus nerve simulation (VNS) for epilepsy.
VNS provides scheduled stimulation (open-loop) to the left vagus nerve to reduce
seizure frequency by a yet unclear mechanism. However, seizure freedom is rare, and
only 30– 40% of patients show a significant decrease in seizure frequency [3]. More
recently, there has been growing interest in the development of responsive therapeutic
devices to abort seizures at their onset. The responsive device (detection and treatment)
identifies seizures at their onset and triggers focal treatment to the epileptogenic zone
to abort the seizure, whether by electrical stimulation, cooling, or drug release. To do
so, an efficient seizure detection algorithm is required for accurate seizure onset
detection without false alarms, and which can be implemented in a custom integrated
circuit. Already, one such type of device is undergoing clinical trial for refractory partial
epilepsy: the cranially implanted Responsive Neurostimulator (RNS) [3].
In this review, we discuss the novel alternative approaches to the treatment of
epilepsy and propose a low-power implantable detection and treatment device.
2. NEUROSTIMULATION TREATMENT OF REFRACTORY EPILEPSY
Drug-resistant partial epileptics are not considered to be good candidates for epilepsy
surgery; thus, alternative treatments are required. Many studies suggest that the new
technologies are promising for the treatment of epilepsy. Given the experiences to date,
focal brain stimulation therapy has proven to be an effective therapy and has been
receiving attention as an alternative therapy for refractory patients. There are two
approaches to brain stimulation: open- and closed-loop. In the former, brain stimulation
is scheduled, while in the latter the stimulation is triggered upon detection of a seizure
[3]. The advantages of the closed-loop stimulation over the open-loop method are (i)
lower number of treatments, (ii) lower adverse effects, (iii) high efficiency because of
rapid access, and (iv) shorter investigation [4]. However, the disadvantages are the
needs to identify the epileptogenic zone, to distinguish ECoG patterns and to stimulate
the brain at earlier stage. The details of the closed-loop brain stimulation approach
are discussed below.
2.1. Closed-Loop Responsive Treatment for Epilepsy
Proof-of-concept experiments conducted in animals and humans with epilepsy have
demonstrated that focal electrical, thermal, or pharmacological manipulations of the
epileptogenic zone can suppress seizure activity, paving the way for a novel approach
to the treatment of epilepsy [3]. Some of these experiments demonstrated the feasibility
of responsive treatment [3–5]. The responsive treatment should be able to analyze the
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intracerebral EEG, detect the seizure onset, and deliver focal treatment to inhibit the
epileptiform activity. However, several issues remain to be addressed, such as the
necessity of a reliable seizure detection system sensitive enough to detect seizures early
on but also specific enough to prevent unwarrantedly triggered focal intervention.
Algorithms of the seizure detection and types of brain stimulation are described below.
2.1.1. Seizure Detection
Several mathematical models have been developed to detect seizures. Intracerebral
EEG-based models have shown much better performance than scalp EEG-based
models, as lesser artifacts are encountered with the former. Table 1 briefly summarizes
different detection algorithms.
These models were developed using desktop computers for off-time data processing.
These types of algorithms cannot be employed in a low-power implantable microchip.
So far, very few implantable devices have been proposed for seizure detection. A
seizure detection algorithm [18] was proposed for an implantable device and realized
with a finite impulse response (FIR) band-pass filter and 15 amplifiers with each
amplifier implemented with DC gain, input noise, and GBW of 100 dB, < 200 μVrms
and 35 kHz, respectively.
An epileptic seizure detector in a custom low-power CMOS integrated circuit that
could run for 7 to 10 years with a rechargeable battery was designed and implemented
by our team [19, 20]. The details of this detector are discussed in section 3.
2.1.2. Focal Electrical Stimulation
In a pilot trial, Osorio et al. demonstrated the feasibility and short-term safety of
automated high-frequency electrical stimulation in blocking seizures using an external
prototype comprising an electrocorticography acquisition system, a computer, and a
stimulator (Grass S12) [4]. Another external responsive neurostimulator (eRNS) has
been shown to terminate electrographic seizures as well [5]. Apart from seizure
detection performance, the other concerns are the safety of chronic electrical
stimulation and the determination of optimal stimulation parameters. It is generally
agreed that limiting the maximum charge density to 30 μC/cm2 per phase can avoid
tissue damage [21]; however, no cell damage in human cortex has been found for 50 to
60 μC/cm2 per phase stimulation [22]. In fact, continuous deep brain stimulation (DBS)
featuring, for example, 1–10 V, 90 μsec pulse width, 100–165 Hz frequency for the
treatment of Parkinson’s disease has been shown to be safe and effective as evidenced
by US-FDA approval [21]. A 1 minute on and 5 minute off stimulation paradigm was
used during an investigational DBS trial for epilepsy [3, 21].
Most of the reported experiments have shown abortion of seizure activity by
electrical stimulation, but there is indication that low-frequency stimulation (lower than
10 Hz delivered to either posterior hypothalamus or thalamus) may induce a seizure 
[3, 21]. It may very well be that proper stimulation parameters need to be individualized
during the presurgical intracerebral EEG study for maximum efficacy prior to the
implantation of a closed-loop responsive stimulation device. Many stimulation
parameters have shown promising performance. For example, Osorio et al. used a
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Table 1. Summary of seizure detection algorithms
Authors Method Description Application
McSharry Multi-modal Time evolution of the SESD
et al. [6] probability probability density function.
evaluation
Shoeb et al. [7] Wavelet and Wavelet decomposition SESD
neural network constructs feature vector and 
the support-vector machine 
classification algorithm 
that determine seizure onset.
Suffczynski Bistable Predict time of seizure occurrences IEBSD
et al. [8] mathematical using a Poisson process and a 
model random walk process.
Moxon et al. [9] Correlation Similarity between a reference IEBSD
and dynamically recorded signal.
Iasemidis et al. Nonlinear,  Convergence and divergence of IEBSD
[10] Lyapunov short-term maximum Lyapunov 
exponent exponents (STLmax) among 
critical electrode sites.
Iasemidis et al. Phase changes Measure average angular IEBSD
[11] frequency and optimize 
the techniques.
Mormann et al. Coherence Statistical measurement of phase IEBSD
[12] synchronization of signals.
Tetzlaff Features Automated technique for the IEBSD
et al. [13] extraction detection of a preseizure state.
Arnhold et al. [14] Signals Detect weak interdependences IEBSD
synchronization of signal.
Nagaraj et al. [15] Synchronization Cross-correlationship used to IEBSD
find dissimilarity of signals 
between interictal periods 
and epileptic seizures.
Sukhi et al. [16] Bayes’ theorem Spectral feature extraction, Bayes’ IEBSD
theorem and spatiotemporal 
analysis.
Yadav et al. [17] Evolution-based Temporal evolution-based nonlinear IEBSD
data adaptive data adaptive classifier utilizing 
classifier linear and nonlinear features and 
mimics human experts for 
classification.
SESD: Scalp EEG recording and software in desktop computer.
IEBSD: Intracranial electrodes, band pass filter and software in desktop computer.
biphasic, charge-balanced square pulse (100 μsec/phase width, 100–500 Hz frequency)
for 1 sec [4]. If the stimulation failed to terminate the seizure, the next seizure detection
begins within 1 minute. A maximum of five stimulations are allowed to terminate a
seizure [4]. In another example, brief bursts of 50 Hz biphasic stimulation for 0.3–2 sec
delivered via subdural electrodes were used [21]. The RNS also uses biphasic, charge-
balanced electric pulses (1– 200 Hz frequency, 0.5 to 12 mA current, 40 to 1000 μs
pulse width, burst duration ≤ 5 sec, and 1 to 5 bursts) [3, 22]. Our research team has so
far proposed some implantable electrical stimulators for different applications, with a
wide range of selectable stimulation parameters that provide a flexible framework for
intervention via a low-power stimulator for the treatment of epilepsy [23, 25].
2.1.3. Focal Drug Delivery
The currently available orally administrated antiepileptic drugs are associated with
variable systemic side effects (adverse effects in liver, bone marrow, and central
nervous system). Focal drug delivery directly onto the epileptogenic zone could
enhance the efficacy of drugs while limiting side effects to a minimum. Experiments in
the past showed that focal diazepam infusion using a programmable pump in response
to automated seizure detection could suppress the seizure [26, 27]. Other drugs such as
DP-valproic acid [28], gabapentin [29], and adenosine [30] have been used but with less
success. Much work lies ahead prior to clinical application in optimal drug selection, the
delivery system, automated seizure detection, the refilling procedure, etc. To date,
technological barriers limit the exploration of direct drug delivery for the long-term
treatment of focal epilepsy.
2.1.4. Focal Cooling with Thermoelectric Devices
Similar to focal drug delivery, focal cooling triggered by the detection of a seizure may
represent an efficient approach to abort seizures on demand without the risk of systemic
side effects. Cooling can reduce end-plate potentials, alter the neuronal action potential,
inhibit the Na-K ATPase [31], reduce the release of presynaptic transmitters, and
decrease neuronal conduction [32, 33]. Recent studies using miniaturized Peltier
devices constitute proof-of-concept that focal cooling can be effective in suppressing
seizure activity [34–36]. However, issues pertaining to high-power consumption and
heat dissipation (risk of thermal damage to adjacent tissues) still need to be addressed.
2.2. Implantable Devices for the Treatment of Epilepsy
Few implantable devices for the treatment of epilepsy have been commercialized. The
only FDA-approved implantable device for the treatment of epilepsy is the vagal nerve
stimulator (VNS). The VNS is an open-loop (non-responsive) system comprising an
implantable stimuli generator, a lead incorporating a bipolar electrode, and an external
pulse programming system for the stimuli generator (see table 2).
The stimuli generator of the VNS is implanted underneath the left clavicle under
general anesthesia. The lead is tunnelled to the neck, and the two helical bipolar
stimulating electrodes are placed around the left vagus nerve. After the operation, the
VNS can be turned on by a computer and programming wand. The most common
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settings for the stimulator are a frequency of 20–30 Hz, a pulse width of 250–500 μs,
time on of 30 s, and time off of 3–5 min. The advantages of VNS include (a) no need
of the exact delineation of the epileptogenic zone , (b) no craniotomy, (c) a lower rate
of surgical complications, and (d) mild and infrequent side effects due to stimulation
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Table 2. Comparison of two commercially available neurostimulators for the
treatment of epilepsy
VNS RNS
FDA approved Clinical trial
Vagal Nerve Stimulation Neuropace RNS-300
Cyberonic Inc. Mountain Biew,
Houston, USA California, USA
Features: Features:
• Battery powered • Battery Powered
• Stimulate vagus nerve • Controlled by microcontroller
• External remote • Store neural signal
• Applicable for refractory generalized • Detect signature of seizure onset
and focal epilepsy. • Applicable for motor simple partial 
seizure and complex partial seizure
Min dose Max dose Min dose Max dose
Stimulation 0.25 mA 3.5 mA Stimulation 1 mA 12 mA
Parameters 30 Sec ON 30 sec ON Parameters 40 m sec PW 1000 m sec PW
3 hr OFF 5 min OFF
130 msec PW 500 msec PW
Frequency 0.25 Hz 30 Hz Frequency 1 Hz 333 Hz
Source: [3, 37-38] Source: [3, 22, 39]
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(hoarseness, cough). The main disadvantage is that, while 30–40% of cases show a
reduction in seizure frequency of more than 50%, only about 3% attain seizure freedom
(long-term effect on seizure frequency) [37–38].
DBS has also been tried for treating epilepsy by providing scheduled stimulation
(open-loop) via depth electrodes to such targets as the hippocampus, thalamus,
cerebellum, caudate nucleus and centromedian thalamus, anterior thalamic nucleus, and
neocortical seizure foci [39, 40]. However, the mechanisms of DBS for stimulation of
the brain in the treatment of epilepsy is yet unknown, and unfortunately, the results so
far have been contradictory [3, 40].
More recently, the cranially implanted Responsive Neurostimulator (RNS, closed-
loop) system has been proposed for the treatment of refractory epilepsy [3]. It consists
of a programmable, battery-powered microprocessor-controlled device (the RNS
neurostimulator) implanted in the cranium, which delivers a short train of electrical
pulses to the epileptogenic zone through intracranial electrodes (depth and cortical strip
leads) when seizure onset is detected. An external programmer, laptop computer,
wand, and telemetry interface enable communication with the implanted RNS
neurostimulator, allowing the physician to modify the parameters of detection and
stimulation of RNS through wireless communication. This investigational responsive
device is still under clinical trial [22, 39]. Table 2 compares the RNS features with those
of the VNS.
3. THE PROPOSED IMPLANTABLE DEVICE FOR EPILEPSY TREATMENT
The recent surging interest and growing clinical needs have motivated us to propose a
fully integrated device which includes a low-power detector and stimulator as well as a
drug-delivery bio-MEMS-based module. This device is intended to perform efficient
seizure detection and subsequent treatment. The proposed closed-loop automated
system is designed for patients with partial (focal) seizure. The proposed device
contains a patient-specific (tunable) seizure onset detector and controllable stimuli
generator. The overall system will be triggered by the electrical stimulation of a targeted
brain area in response to a low-voltage fast activity seizure pattern. Figure 2 shows an
intracerebral recording of a typical low-voltage fast activity as seen at seizure onset
over the epileptogenic area, with subsequent evolution in frequency and amplitude as
the seizure progresses and propagates to other electrode contacts. The proposed system
detects the seizure onset and stimulates neural tissues to terminate the seizure
progression and propagation.
Figure 3a illustrates the implant configuration while Figs. 3b and 3c show the block
diagram of the proposed implantable device and the flowchart of the closed-loop
automated system, respectively. Wireless transmission to an external device allows the
clinician to review intracerebral recordings, and to modify the parameters of seizure
detection and electrical stimulation as required. The flowchart of the closed-loop
system shows that electrical stimulation therapy is activated in response to seizure
detection.
Our research group has proposed several low-power implantable preamplifiers for
neural signal amplification [41–46] and more recently, low-power implantable
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Partial seizure
Focal: Seizure activities begin
in an epileptogenic zone Spreading to the
adjacent regions
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generalized seizure
Figure 2. Intracerebral EFG recordings of a patient with refractory focal epilepsy
[source: Centre Hospitalier de 1′Université de Montréal].
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Figure 3. (a) Illustration of the implant configuration, (b) block diagram of the
implantable device, and (c) flowchart of the closed-loop automated system.
integrated devices for automatic seizure detection [19, 20]. The experimental validation
of our seizure detector prototype is under-way. The proposed implantable seizure onset
detector (SOD) provides continuous long-term monitoring of intracerebral EEG. The
sensitivity of the SOD is enhanced, and several decision boundaries are introduced to
reduce the number of false alarms based on the patient’s specific seizure pattern. Signal
analysis of this SOD demonstrates that through early modulation and proper
rectification of the intracerebral signal, the seizure onset information can be efficiently
extracted. Therefore, the detected hyperexcitation of the intracerebral signal is accurately
analyzed over a certain time frame. The duration of the detected hyperexcitation then
indicates an upcoming seizure event. Furthermore, this SOD determines the high-
frequency patterns and the progressive amplitude increase of the seizure signal.
Because the ictal patterns vary from patient to patient according to the underlying
substrate, the type of intracerebral electrodes used, and their locations with respect to
the epileptogenic zone, the seizure detection algorithm requires several adjustable
parameters for optimal sensitivity and specificity.
As some patients with refractory epilepsy also present numerous asymptomatic brief
electrical seizures (in addition to the less frequent electroclinical seizures), the
physician may decide to adjust the seizure detection parameters to trigger or withhold
focal stimulation at those asymptomatic discharges. For some patients, one could elect
not to trigger stimulation (or any other type of focal treatment) at these frequent, brief
and silent events to spare battery life.
Figure 4 shows the intracerebral EEG recording of a brief electrical seizure followed
by an electroclinical seizure. The recording is analyzed with Matlab software, and a
seizure detection algorithm for partial-onset seizures is employed. In this algorithm, the
input signal is modulated into high frequency (Fs = 1/Ts) so that instrumentation low-
frequency noise does not affect the signal. The discrete signal confined to a time frame
(Tf ) passes through N number of voltage level detectors (VLD) to detect the specific
features of a progressive hyperexcited signal. The threshold voltages of VLD and Tf are
tuned to the specific seizure onset frequency of a patient to minimize false alarms.
Figure 4a demonstrates the seizure detection algorithm on a signal confined to Tf =
2 sec. The normal, electrical seizure and electroclinical seizure patterns are modulated
(Figs. 4a1– 4a14), and each of these modulated signals pass through four VLDs
(threshold voltages are shown in Fig. 4b1). The high number of detections in Fig.
4b1– 4b14 reflects the high frequency of the signal and the similar numbers of detection
represent progressive increases in the signal as seen during a seizure. Figures 4c1–4c14
show the frequency analysis of these signal patterns. Hence, the algorithm is able to
determine the high frequency as well as the progressive increase in the amplitude
(Fig. 4b12–4b13) of the seizure signal. To further minimize false alarms, an adjustable
time frame (two seconds in this example) of high-frequency electrical seizure is set
(Fig. 4c6–4c7). The detection performance was recently verified using intracerebral
EEG recordings from different patients with refractory epilepsy. A 30-year-old patient
with intractable epilepsy underwent left craniotomy for invasive EEG evaluation, and
the detection performance of a low power (6.71 μW) CMOS integrated low-voltage fast
activity seizure onset detector was verified using this recorded EEG signal [20].
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Another detector (6.72 μW) was verified using intracerebral electroencephalographic
recordings from a 27-year-old patient with intractable epilepsy and the detector
accurately identified seizure onsets [19].
The seizure detector enables the electrical stimulator to deliver a burst of electrical
pulses via intracranial electrodes (Fig. 3a). The dimensions of these intracranial
electrodes could be relatively standard (e.g., 2–4 mm in diameter), and the interelectrode
spacing of 10 mm [1] or custom made (Fig. 5a) depending on the size and location of the
epileptogenic zone as delineated from an in-patient invasive monitoring study.
Effective individualized stimulation parameters could also have been identified
during the in-hospital invasive monitoring study. With respect to the safety limits of
chronic electrical stimulation, the proposed system can provide a high-frequency (100
to 500 Hz) biphasic and charge-balanced square wave (Fig. 5b) up to a maximum of
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Figure 4. Detection of an epileptic seizure onset: (a) Invasive EFG recording of a
patient with refractory focal epilepsy, (a1)–(a14) are modulated signals
for every 2 sec of (a), (b1)–(b14) are the output of the voltage level
detector, and (c1)–(c14) show the frequency analysis of the signals for
every 2 sec of (a).
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five stimulations for a seizure. If desired, the clinician could always modify the
stimulation parameters through wireless communication. For example, the low-power
wireless transceiver RFM TRC-104 (RF Monolithics, Inc.) is known to be reliable, safe,
and flexible for data transmission. Overall, the total estimated power consumption of
the proposed system is less than 13 mW. Therefore, the whole device could theoretically
run on a button lithium ion battery for 2 to 3 years. Replacing the battery would not
require a major surgical procedure.
4. CONCLUSION
Drug-resistant patients with epilepsy may be candidates for non-pharmacological
therapies, such as implantable medical devices. So far, three devices are commercially
available for the treatment of epilepsy, and a number of strategies hold promise for
improving their effectiveness. There are advantages and drawbacks of these available
implantable devices, specifically in seizure onset detection and neurostimulation of
cortical epileptogenic focus to stop the progression of seizures. Closed-loop implantable
responsive systems for the focal treatment of refractory partial epilepsy are promising
therapeutic avenues that show potential for effective treatment with minimal side effects.
A fully integrated tunable implantable system responsive to ictal low-voltage fast
activity patterns is being developed with a wireless fully programmable neurostimulator
integrated to ensure precise interaction with the epileptogenic focus. Novel approaches
in direct electrical stimulation, drug delivery, thermal cooling, and new subdural
electrode design should offer a chance for long-term seizure remission or even cure.
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Figure 5. (a) The custom-made subdural electrodes and (b) the biphasic charge-
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